Consistent with our result, Nishida-Aoki et al. demonstrated that the depletion of EVs with anti-CD9 or CD63 antibodies failed to inhibit tumor growth at the primary site despite the suppression of metastasis [18]. Here, CD9 is linked to neoplasm.